VEEV

Veeva Systems Inc. NYSE

Healthcare ·Medical - Healthcare Information Services ·US · veeva.com

$171.60

Mkt Cap $28.7B

52w Low $148.05 14.5% of range 52w High $310.50

50d MA $175.35 200d MA $238.64

P/E (TTM) 30.9x

EV/EBITDA 35.0x

P/B 3.9x

Debt/Equity 0.0x

ROE 12.6%

P/FCF 24.1x

RSI (14) —

ATR (14) —

Beta 1.10

50d MA $175.35

200d MA $238.64

Avg Volume 2.3M

About

Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud, a suite of software, data, and analytics solutions, which include Veeva customer relationship management (CRM) and Veeva Medical CRM, Veeva CLM, Veeva CRM MyInsights, Veeva CLM, Veeva CRM A…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	1M%	Guide ▲★
Mar 4, 2026	AMC	1.94	2.06	+6.2%	188.48	+6.9%	+4.0%	+3.7%	+3.8%	+0.6%	-0.7%	-7.3%	—
Nov 20, 2025	AMC	1.95	2.04	+4.6%	270.50	-7.7%	-9.8%	-12.9%	-11.3%	-11.0%	-11.2%	-17.4%	—
Aug 27, 2025	AMC	1.90	1.99	+4.7%	293.59	-2.8%	-7.2%	-8.3%	-8.0%	-7.7%	-8.0%	-1.1%	—
Mar 5, 2025	AMC	1.60	1.74	+8.8%	219.94	+5.9%	+7.4%	+12.2%	+9.0%	+5.3%	+6.1%	-2.8%	—
Dec 5, 2024	AMC	1.58	1.75	+10.8%	231.66	+7.9%	+8.1%	+6.2%	+6.3%	+0.9%	+0.4%	-8.1%	—
Aug 28, 2024	AMC	1.53	1.62	+5.9%	199.35	+7.4%	+8.9%	+8.6%	+8.2%	+8.8%	+8.0%	+5.8%	—
May 30, 2024	AMC	1.42	1.50	+5.6%	194.19	-9.9%	-10.3%	-11.7%	-7.9%	-6.4%	-4.7%	-6.4%	—
Feb 29, 2024	AMC	1.30	1.38	+6.2%	225.51	-1.9%	-1.6%	+0.2%	-1.7%	-0.4%	+2.1%	+2.2%	—
Dec 6, 2023	AMC	1.28	1.34	+4.7%	178.39	-2.8%	-3.0%	-3.2%	-2.2%	-1.8%	-0.6%	+4.1%	—
Aug 30, 2023	AMC	1.12	1.21	+8.0%	192.59	+2.9%	+8.4%	+12.5%	+14.2%	+15.5%	+15.3%	+5.6%	—
May 31, 2023	AMC	0.79	0.91	+15.2%	165.70	+14.1%	+19.7%	+17.7%	+16.7%	+18.3%	+14.0%	+19.3%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Apr 10	Citigroup	Downgrade	Buy → Neutral	—	$157.08	$153.06	-2.6%	-3.6%	+0.9%	+1.3%	+6.5%	+6.8%
Mar 9	Citigroup	Maintains	Buy → Buy	—	$195.49	$194.27	-0.6%	+0.0%	-3.0%	-4.3%	-7.5%	-8.5%
Mar 5	TD Cowen	Maintains	Buy → Buy	—	$188.48	$201.50	+6.9%	+4.0%	+3.7%	+3.8%	+0.6%	-0.7%
Mar 5	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$188.48	$201.50	+6.9%	+4.0%	+3.7%	+3.8%	+0.6%	-0.7%
Mar 5	UBS	Maintains	Neutral → Neutral	—	$188.48	$201.50	+6.9%	+4.0%	+3.7%	+3.8%	+0.6%	-0.7%
Mar 5	Wells Fargo	Maintains	Overweight → Overweight	—	$188.48	$201.50	+6.9%	+4.0%	+3.7%	+3.8%	+0.6%	-0.7%
Mar 5	Canaccord Genuity	Maintains	Hold → Hold	—	$188.48	$201.50	+6.9%	+4.0%	+3.7%	+3.8%	+0.6%	-0.7%
Mar 5	Evercore ISI	Maintains	In Line → In Line	—	$188.48	$201.50	+6.9%	+4.0%	+3.7%	+3.8%	+0.6%	-0.7%
Mar 5	RBC Capital	Maintains	Outperform → Outperform	—	$188.48	$201.50	+6.9%	+4.0%	+3.7%	+3.8%	+0.6%	-0.7%
Mar 5	Needham	Maintains	Buy → Buy	—	$188.48	$201.50	+6.9%	+4.0%	+3.7%	+3.8%	+0.6%	-0.7%
Mar 5	Truist	Maintains	Buy → Buy	—	$188.48	$201.50	+6.9%	+4.0%	+3.7%	+3.8%	+0.6%	-0.7%
Mar 5	Piper Sandler	Maintains	Overweight → Overweight	—	$188.48	$201.50	+6.9%	+4.0%	+3.7%	+3.8%	+0.6%	-0.7%
Mar 5	Stifel	Maintains	Buy → Buy	—	$188.48	$201.50	+6.9%	+4.0%	+3.7%	+3.8%	+0.6%	-0.7%
Feb 26	Stifel	Maintains	Buy → Buy	—	$176.46	$176.41	-0.0%	+3.6%	+3.1%	+2.8%	+5.4%	+6.8%
Feb 25	Barclays	Maintains	Overweight → Overweight	—	$175.79	$175.32	-0.3%	+0.4%	+4.0%	+3.5%	+3.2%	+5.8%
Feb 24	Oppenheimer	Maintains	Outperform → Outperform	—	$172.17	$174.01	+1.1%	+2.1%	+2.5%	+6.2%	+5.7%	+5.4%
Feb 20	JP Morgan	Maintains	Overweight → Overweight	—	$182.57	$182.40	-0.1%	-1.2%	-5.7%	-3.7%	-3.3%	+0.2%
Feb 20	UBS	Maintains	Neutral → Neutral	—	$182.57	$182.40	-0.1%	-1.2%	-5.7%	-3.7%	-3.3%	+0.2%
Feb 17	Morgan Stanley	Upgrade	Underweight → Equal Weight	—	$174.11	$178.30	+2.4%	+1.6%	+4.1%	+4.9%	+3.6%	-1.1%
Dec 12	KeyBanc Capital Markets	Downgrade	Overweight → Sector Weight	—	$229.49	$216.01	-5.9%	-2.7%	-4.1%	-4.4%	-6.1%	-5.0%
Nov 25	Wells Fargo	Maintains	Overweight → Overweight	—	$235.74	$236.81	+0.5%	+1.8%	+2.1%	+1.9%	+2.0%	+1.9%
Nov 24	Citigroup	Maintains	Buy → Buy	—	$244.06	$244.90	+0.3%	-3.4%	-1.7%	-1.4%	-1.5%	-1.5%
Nov 21	BTIG	Maintains	Buy → Buy	—	$270.50	$249.75	-7.7%	-9.8%	-12.9%	-11.3%	-11.0%	-11.2%
Nov 21	Barclays	Maintains	Overweight → Overweight	—	$270.50	$249.75	-7.7%	-9.8%	-12.9%	-11.3%	-11.0%	-11.2%
Nov 21	Canaccord Genuity	Maintains	Hold → Hold	—	$270.50	$249.75	-7.7%	-9.8%	-12.9%	-11.3%	-11.0%	-11.2%
Nov 21	Needham	Maintains	Buy → Buy	—	$270.50	$249.75	-7.7%	-9.8%	-12.9%	-11.3%	-11.0%	-11.2%
Nov 21	Baird	Maintains	Outperform → Outperform	—	$270.50	$249.75	-7.7%	-9.8%	-12.9%	-11.3%	-11.0%	-11.2%
Nov 21	UBS	Maintains	Neutral → Neutral	—	$270.50	$249.75	-7.7%	-9.8%	-12.9%	-11.3%	-11.0%	-11.2%
Oct 17	BTIG	Maintains	Buy → Buy	—	$292.73	$291.19	-0.5%	-3.1%	-2.3%	-1.0%	-1.0%	-0.4%
Oct 17	Needham	Maintains	Buy → Buy	—	$292.73	$291.19	-0.5%	-3.1%	-2.3%	-1.0%	-1.0%	-0.4%
Oct 7	TD Cowen	Upgrade	Hold → Buy	—	$299.76	$306.82	+2.4%	+2.2%	+0.7%	-0.4%	-4.4%	-4.6%
Sep 8	JP Morgan	Upgrade	Neutral → Overweight	—	$272.93	$279.00	+2.2%	+3.6%	+3.6%	+0.6%	+2.4%	+1.3%
Aug 29	Mizuho	Maintains	Outperform → Outperform	—	$272.33	$272.56	+0.1%	-1.1%	-0.9%	-0.5%	-0.8%	+0.2%
Aug 28	Evercore ISI	Maintains	In Line → In Line	—	$293.59	$285.34	-2.8%	-7.2%	-8.3%	-8.0%	-7.7%	-8.0%
Aug 28	BTIG	Maintains	Buy → Buy	—	$293.59	$285.34	-2.8%	-7.2%	-8.3%	-8.0%	-7.7%	-8.0%
Aug 28	Barclays	Maintains	Overweight → Overweight	—	$293.59	$285.34	-2.8%	-7.2%	-8.3%	-8.0%	-7.7%	-8.0%
Aug 28	Wells Fargo	Maintains	Overweight → Overweight	—	$293.59	$285.34	-2.8%	-7.2%	-8.3%	-8.0%	-7.7%	-8.0%
Aug 28	JP Morgan	Maintains	Neutral → Neutral	—	$293.59	$285.34	-2.8%	-7.2%	-8.3%	-8.0%	-7.7%	-8.0%
Aug 28	Raymond James	Maintains	Outperform → Outperform	—	$293.59	$285.34	-2.8%	-7.2%	-8.3%	-8.0%	-7.7%	-8.0%
Aug 28	Needham	Maintains	Buy → Buy	—	$293.59	$285.34	-2.8%	-7.2%	-8.3%	-8.0%	-7.7%	-8.0%
Aug 28	Canaccord Genuity	Maintains	Hold → Hold	—	$293.59	$285.34	-2.8%	-7.2%	-8.3%	-8.0%	-7.7%	-8.0%
Aug 28	Piper Sandler	Maintains	Overweight → Overweight	—	$293.59	$285.34	-2.8%	-7.2%	-8.3%	-8.0%	-7.7%	-8.0%
Aug 28	UBS	Maintains	Neutral → Neutral	—	$293.59	$285.34	-2.8%	-7.2%	-8.3%	-8.0%	-7.7%	-8.0%
Aug 28	Morgan Stanley	Maintains	Underweight → Underweight	—	$293.59	$285.34	-2.8%	-7.2%	-8.3%	-8.0%	-7.7%	-8.0%
Aug 28	Truist	Maintains	Hold → Hold	—	$293.59	$285.34	-2.8%	-7.2%	-8.3%	-8.0%	-7.7%	-8.0%
Aug 28	Citigroup	Maintains	Buy → Buy	—	$293.59	$285.34	-2.8%	-7.2%	-8.3%	-8.0%	-7.7%	-8.0%
Aug 28	Stifel	Maintains	Buy → Buy	—	$293.59	$285.34	-2.8%	-7.2%	-8.3%	-8.0%	-7.7%	-8.0%
Aug 28	Oppenheimer	Maintains	Outperform → Outperform	—	$293.59	$285.34	-2.8%	-7.2%	-8.3%	-8.0%	-7.7%	-8.0%
Aug 26	Wells Fargo	Maintains	Overweight → Overweight	—	$285.18	$288.03	+1.0%	+0.5%	+2.9%	-4.5%	-5.6%	-5.3%
Jul 14	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$275.89	$276.70	+0.3%	+2.3%	+1.2%	+2.4%	+0.2%	+2.3%

Recent Filings

8-K · 5.02 !!! Very High

Veeva Systems Inc. -- 8-K 5.02: Executive Change

Veeva Systems appoints Josh Faddis as a director, expanding its board with what appears to be a strategic leadership addition to guide the cloud software company's future decisions.

Apr 20

8-K

Veeva Systems Inc. -- 8-K Filing

Veeva Systems delivered strong FY2026 results with 16% revenue growth to $3.2 billion and 17% subscription revenue growth, demonstrating solid execution in its cloud-based enterprise software business.

Mar 4

Data updated apr 27, 2026 7:28am · Source: massive.com